Meanwhile, podocin and nephrin were raised in the diabetic mouse kidney, and urine podocalyxin was decreased in mice with experimental diabetes after valsartan or TSWN treatment (Figures 6A–C). The gene discussed is NPHS2; the disease is diabetes mellitus.